SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Form
Filing Date
Oct 2, 2018
Document Date
Sep 28, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS INC
Filer
Knickerbocker Aron Marc